gMendel Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1.99M
- Investors
-
6
gMendel General Information
Description
Developer of a comprehensive decision support software designed to transform the diagnosis of genetic disorders for better disease management. The company specializes in combining genomics, machine learning, and blockchain to diagnose genetic disorders and provide comprehensive decision support software, which allows for accurate and timely diagnosis of genetics, enabling healthcare professionals with a shorter, safer, and more economical path to accurate diagnosis of genetic disorders and potential treatment.
Contact Information
Website
www.g-mendel.comCorporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
Corporate Office
- Fruebjergvej 3
- 2100 Copenhagen
- Denmark
gMendel Timeline
gMendel Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 15-Apr-2026 | $1.99M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Seed Round | 01-Dec-2023 | Completed | Generating Revenue | |||
| 4. Grant | 04-Jan-2023 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jan-2020 | $342K | $342K | Completed | Startup | |
| 1. Corporate | 20-Feb-2023 | Completed | Startup |
gMendel Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 218 | $248.21 | $248.21 | 1x | $248.21 | 0.42% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
gMendel Patents
gMendel Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4532754-A1 | A computer implemented method for identifying, if present, a preselected genetic disorder | Pending | 01-Jun-2022 | ||
| US-20260245657-A1 | A computer implemented method for identifying, if present, a preselected genetic disorder | Pending | 01-Jun-2022 | ||
| WO-2023232940-A1 | A computer implemented method for identifying, if present, a preselected genetic disorder | Inactive | 01-Jun-2022 | C12Q1/6869 |
gMendel Signals
gMendel Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Metavallon VC | Venture Capital | Minority | ||
| Nordic Asian Venture Alliance | Venture Capital | Minority | ||
| CVX Ventures | Venture Capital | Minority | ||
| Eurostars | Other | Minority | ||
| Innovationsfonden | Accelerator/Incubator | Minority |
gMendel FAQs
-
When was gMendel founded?
gMendel was founded in 2020.
-
Where is gMendel headquartered?
gMendel is headquartered in Copenhagen, Denmark.
-
What is the size of gMendel?
gMendel has 12 total employees.
-
What industry is gMendel in?
gMendel’s primary industry is Decision/Risk Analysis.
-
Is gMendel a private or public company?
gMendel is a Private company.
-
What is the current valuation of gMendel?
The current valuation of gMendel is .
-
What is gMendel’s current revenue?
The current revenue for gMendel is .
-
How much funding has gMendel raised over time?
gMendel has raised $3.46M.
-
Who are gMendel’s investors?
Metavallon VC, Nordic Asian Venture Alliance, CVX Ventures, Eurostars, and Innovationsfonden are 5 of 6 investors who have invested in gMendel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process